Propel Bio Management’s SpyGlass Pharma SGP Stock Holding History
Bought
Maintained
Sold
Other funds holding SGP
Propel Bio Management's SGP Position: Q3 2026 in Review
Propel Bio Management opened a new position in SpyGlass Pharma (SGP) in Q3 2026: 41,418 shares worth $1.08M. The stake represents 0.57% of the portfolio and ranks #29 among its holdings.
70 funds tracked by Wall St. Rank hold SGP as of Q3 2026.
- Propel Bio Management held 41,418 shares of SpyGlass Pharma worth $1.08M as of Q3 2026.
- SpyGlass Pharma was a new Propel Bio Management position in Q3 2026.
- SpyGlass Pharma made up 0.57% of Propel Bio Management's portfolio in Q3 2026, its #29 holding.
- 70 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.
Based on Propel Bio Management's 13F filing for Q3 2026, filed 13 Nov 2026.